Plasma terminal half-life

被引:265
作者
Toutain, PL [1 ]
Bousquet-Mélou, A [1 ]
机构
[1] ENVT, INRA, UMR Physiopathol & Toxicol Expt 181, F-31076 Toulouse 03, France
关键词
D O I
10.1111/j.1365-2885.2004.00600.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Terminal plasma half-life is the time required to divide the plasma concentration by two after reaching pseudo-equilibrium, and not the time required to eliminate half the administered dose. When the process of absorption is not a limiting factor, half-life is a hybrid parameter controlled by plasma clearance and extent of distribution. In contrast, when the process of absorption is a limiting factor, the terminal half-life reflects rate and extent of absorption and not the elimination process (flip-flop pharmacokinetics). The terminal half-life is especially relevant to multiple dosing regimens, because it controls the degree of drug accumulation, concentration fluctuations and the time taken to reach equilibrium.
引用
收藏
页码:427 / 439
页数:13
相关论文
共 12 条
[1]   We may not measure the correct intestinal wall permeability coefficient of drugs: Alternative absorptive clearance concept [J].
Chiou, WL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (03) :323-331
[2]   The pharmacokinetics of dexamethasone in the Thoroughbred racehorse [J].
Cunningham, FE ;
Rogers, S ;
Fischer, JH ;
Jensen, RC .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (01) :68-71
[3]   THE BATEMAN FUNCTION REVISITED - A CRITICAL REEVALUATION OF THE QUANTITATIVE EXPRESSIONS TO CHARACTERIZE CONCENTRATIONS IN THE ONE-COMPARTMENT BODY MODEL AS A FUNCTION OF TIME WITH FIRST-ORDER INVASION AND FIRST-ORDER ELIMINATION [J].
GARRETT, ER .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (02) :103-128
[4]   ESTIMATION OF VARIANCE FOR HARMONIC MEAN HALF-LIVES [J].
LAM, FC ;
HUNG, CT ;
PERRIER, DG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (02) :229-231
[5]   BRIEF RETROSPECTIVES IN PHARMACOKINETICS - ON ABSORPTION RATE AND FRACTION ABSORBED [J].
RESCIGNO, A .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (03) :255-257
[6]  
RESCIGNO A, 1994, J PHARMACOKINETICS B, V22, P253
[7]   SPECIES DEPENDENT GENTAMICIN PHARMACOKINETICS AND NEPHROTOXICITY IN THE YOUNG HORSE [J].
RIVIERE, JE ;
COPPOC, GL ;
HINSMAN, EJ ;
CARLTON, WW ;
TRAVER, DS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1983, 3 (05) :448-457
[8]   PHARMACOKINETICS OF METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, AND METHYLPREDNISOLONE ACETATE IN DOGS [J].
TOUTAIN, PL ;
KORITZ, GD ;
FAYOLLE, PM ;
ALVINERIE, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (03) :251-255
[9]   Volumes of distribution [J].
Toutain, PL ;
Bousquet-Mélou, A .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) :441-453
[10]   Plasma clearance [J].
Toutain, PL ;
Bousquet-Mélou, A .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) :415-425